Smokers at greater risk of schizophrenia and psychotic disorders

A team of researchers from University of Queensland have found that tobacco use is associated with an increased risk of psychotic disorders including schizophrenia.

The study titled “Evidence of a Causal Relationship Between Smoking Tobacco and Schizophrenia Spectrum Disorders,” was published in the latest issue of the journal Frontiers in Psychiatry.

Image Credit: Sruilk / Shutterstock
Image Credit: Sruilk / Shutterstock

For this study the team looked at eight long term studies and collated the data available to find the evidence that smoking could be linked to mental illnesses. They team suggests that nicotine in tobacco could play a role in these disorders.

According to lead author of the study Associate Professor James Scott this also raises concerns about the rising nicotine use among youngsters in the form of e-cigarettes. He said that those who smoke are at a “two fold” risk of schizophrenia or psychosis as is evident from these studies. He said, “While e-cigarettes reduce some of the harms associated with smoking, governments need to consider their potential to harm the mental health of young people. More research is urgently needed to examine the association between e-cigarette use and psychosis, particularly in adolescents and young adults, until then, liquid nicotine should remain illegal for purchase in Australia without a prescription,” Dr Scott said.

The team looked at eight long term cohort studies. They found that six of the eight showed a statistically significant association between tobacco smoking and psychotic disorders or schizophrenic spectrum disorders or SSD. According to authors SSD includes, “schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, non-affective psychotic disorder, atypical psychosis, psychotic depression, and bipolar mania with psychotic features”. The team adjusted the findings for age, gender, genetic risk, use of other substances such as cannabis, socioeconomic status etc. before coming to the conclusions.

To assess if there was any association, the team used a Bradford Hill Framework which contains nine criteria that can link the exposure to outcome. Of these nine criteria, five were chosen to be highly relevant. All studies were conducted in high income countries. The participants in the studies were followed up for a minimum of 4 years to a maximum of 48 years.

Results showed that there was a six fold rise in risk of schizophrenia in heavy smokers as seen from the strength of association. Only one of the eight studies did not show a causal association between smoking and schizophrenia write the researchers. Overall there was a two-fold rise in risk of schizophrenia among smokers, the researchers write.

The authors of the study explain that there are around 5000 different chemicals in tobacco smoke but nicotine seems to be the main culprit here. There have been studies that have shown that nicotine is capable of altering the signal system of the brain mainly in the “dopaminergic, cholinergic, and glutamatergic neurotransmitter systems,” they explain. This could negatively influence brain maturation in teenagers and young adults. Further this could cause “strengthening of negative emotional changes and alterations in cognitive functioning,” in adolescents they add and this could possibly lead to mental ailments later in life.

Source: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00607/full

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, November 21). Smokers at greater risk of schizophrenia and psychotic disorders. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20181121/Smokers-at-greater-risk-of-schizophrenia-and-psychotic-disorders.aspx.

  • MLA

    Mandal, Ananya. "Smokers at greater risk of schizophrenia and psychotic disorders". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20181121/Smokers-at-greater-risk-of-schizophrenia-and-psychotic-disorders.aspx>.

  • Chicago

    Mandal, Ananya. "Smokers at greater risk of schizophrenia and psychotic disorders". News-Medical. https://www.news-medical.net/news/20181121/Smokers-at-greater-risk-of-schizophrenia-and-psychotic-disorders.aspx. (accessed November 24, 2024).

  • Harvard

    Mandal, Ananya. 2018. Smokers at greater risk of schizophrenia and psychotic disorders. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20181121/Smokers-at-greater-risk-of-schizophrenia-and-psychotic-disorders.aspx.

Comments

  1. Andrew Tyndale Andrew Tyndale Australia says:

    It has long been known that people with SSD are more likely to smoke. Is this study concluding that smoking leads to SSD?

  2. Derek Williams Derek Williams United Kingdom says:

    This has interesting implications for the claims of cannabis leading to mental illness as promoted by Prof Robyn Murray et al. In the UK, cannabis is usually smoked with large amounts of tobacco in joints, a fact that seems to have been ignored in most if not all of the studies into cannabis and mental health. As a result most cannabis users in the UK are very heavy tobacco smokers.

    Despite lobbying over many years, the UK government has consistently refused to run a safer use campaign aimed at cannabis users to deter the use of tobacco in joints.  What makes this worse is these claims of "cannabis psychosis" have been used by the UK government to oppose cannabis law reform.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the genetics of schizophrenia